The Center has asked pharmaceutics to detail with marketing expenditure in the last year, which has tied the industry to custody.
Details required by the Ministry of Pharmaceutical (DOP) must be submitted until 31 July, and failures that measures will be taken against pharmaceutical companies.
The Union Government carefully monitors marketing practice of pharmaceutical companies in the middle of reports on these companies, which continue to offer a number of free doctors, despite a uniform code for pharmaceutical marketing practices (UPMP), which is implemented to control unethical marketing procedures.
Read also: Low vaccine stocks focus on spreading new COVID variants
Communication, dated 29 May, was issued by the government by all pharmaceutical associations to comply with the regulations according to the targeted deadline.
“The Ministry of Pharmaceutical workers (DOP) focused on the submission of self -rendition and publication of marketing expenditure under the Unified Code for Pharmaceutical Marketing Practice (UPMP) 2024.
Self-DeCriving is a legal commitment to be filed by the company’s bosses to ensure that they will not affect any unethical marketing practices to promote their products.
Read also: India puts large pharmaceutical concessions on the table because the US business agreement is close to the target line
Patel said that the implementation of UPPMP instructions has created a company in marketing practice, which is good for this industry.
Sudarshan Jain, General Secretary of the Indian Pharmaceutical Alliance, said: “For the first time, such massive compliance is carried out by pharmacies. The data must be uploaded to the dedicated government portal to become standardized for companies.”
“Our member companies are ready to update financial data on pharmaceutical marketing,” the executive said.
The UCCPMP was introduced in March last year to achieve transparency and ensure ethical behavior in marketing practices of pharmaceutical companies and reduce them free of charge such as gifts, travel, hospitality and monetary benefits for prescribing a particular drug.
According to government data, India is home. 3,000 drugs companies and 10,500 production units. It is assumed that the industry will reach $ 130 billion by 2030.
Questions sent to the Ministry of Pharmaceutical spokesperson remained unanswered until the press.
Read also: Government Warning: Common treatment of antibiotics may be a “threatening life”
The whole exercise is carried out in the background of the discussion of micro laboratories: the Dolo650 mg creators reportedly offered doctors during the freebies pandemic to prescribe anti-fever medicine.
Last year in December, DOP accused Abbvie Healthcare India PVT. LTD violations of UPMP instructions reportedly by sponsoring holiday for 30 healthcare workers to Monaco and Paris. The company could not be contacted to comment.
(Tagstotranslate) Medicine
